BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17331436)

  • 1. [Oral-maxillofacial malignant tumors: an initial study with in vivo single-voxel 1H MR spectroscopy].
    Yu Q; Wang PZ; Shi HM; Luo JC
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):18-20. PubMed ID: 17331436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary assessment of benign maxillofacial and neck lesions with in vivo single-voxel 1H magnetic resonance spectroscopy.
    Yu Q; Yang J; Wang P; Shi H; Luo J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):264-70. PubMed ID: 17630099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
    Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
    Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant tumors and chronic infections in the masticator space: preliminary assessment with in vivo single-voxel 1H-MR spectroscopy.
    Yu Q; Yang J; Wang P
    AJNR Am J Neuroradiol; 2008 Apr; 29(4):716-9. PubMed ID: 18184844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A retrospective clinical study of 6539 cases of malignant oral-maxillofacial tumors].
    Wen Y; Dai X; Wang C; Li L; Fu F; Wang X; Tang X; Liu H; Hua C; Pan J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):296-9. PubMed ID: 12539484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors.
    Lee J; Yamaguchi T; Abe A; Shizukuishi K; Uemura H; Miyagi E; Sakata K; Inoue T
    Radiat Med; 2004; 22(3):148-54. PubMed ID: 15287529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo 1H MR spectroscopy of thyroid carcinoma.
    King AD; Yeung DK; Ahuja AT; Tse GM; Chan AB; Lam SS; van Hasselt AC
    Eur J Radiol; 2005 Apr; 54(1):112-7. PubMed ID: 15797300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor.
    Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K
    Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo proton spectroscopy of giant cell tumor of the bone.
    Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR
    AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
    Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
    Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
    Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
    AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant tumors of orofacial origin in Iran.
    Andisheh Tadbir A; Mehrabani D; Heydari ST
    J Craniofac Surg; 2008 Nov; 19(6):1538-41. PubMed ID: 19098546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo 1H MRS for musculoskeletal lesion characterization: which factors affect diagnostic accuracy?
    Wang CK; Li CW; Hsieh TJ; Lin CJ; Chien SH; Tsai KB; Chang KC; Tsai HM
    NMR Biomed; 2012 Feb; 25(2):359-68. PubMed ID: 21793078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of choroid plexus tumors by advanced magnetic resonance spectroscopy.
    Krieger MD; Panigrahy A; McComb JG; Nelson MD; Liu X; Gonzalez-Gomez I; Gilles F; Bluml S
    Neurosurg Focus; 2005 Jun; 18(6A):E4. PubMed ID: 16048290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
    Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.